Protein Dimerization Interface Mapping via Peptide Labeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Mapping the dimerization interface in monoclonal antibodies is challenging due to the complexity and heterogeneity of mAb dimers, and existing methods like hydrogen-deuterium exchange mass spectrometry are limited in detecting protein side-chain interactions, which hinders the understanding and control of protein aggregation.
Innovation Solution
The development of systems and methods to characterize protein dimerization interfaces at the peptide/residue level by digesting protein dimer samples, labeling, and peptide mapping to identify regions with decreased labeling extents, which are likely involved in dimerization, using techniques such as limited digestion, carboxyl group labeling, and fast photochemical oxidation of proteins (FPOP).
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If hydrogen-deuterium exchange mass spectrometry is used to study protein-protein interactions, then the method can detect some interactions, but it fails to reveal the mAb dimerization interface due to limitations in detecting protein side-chain interactions
Solution Approach 1:
The patent introduces an intermediary labeling step using chemical reagents (such as iodine or other labeling agents) that specifically react with amino acid residues at the dimerization interface. This intermediary labeling process enables indirect detection of side-chain interactions that are otherwise invisible to conventional HDX-MS, thereby resolving the detection limitation while maintaining the overall measurement approach.
Solution Approach 2:
The patent modifies the measurement parameters by incorporating labeling extent quantitation and comparing labeled vs. unlabeled species. This parameter change transforms the detection capability from merely observing hydrogen exchange to specifically detecting side-chain involvement through labeling patterns, thereby enabling reliable identification of the dimerization interface.
2Adaptability or versatility
If conventional methods are used to map dimerization interfaces, then the process is simpler, but the ability to handle complexity and heterogeneity of mAb dimers is insufficient
Solution Approach 1:
The patent segments the complex dimerization analysis into distinct functional modules: (1) sample preparation and dimer enrichment, (2) chemical labeling with detectable markers, (3) separation of labeled species, (4) mass spectrometry analysis, and (5) data processing for interface identification. This segmentation allows each module to be optimized independently while collectively handling the complexity and heterogeneity of mAb dimers.
Solution Approach 2:
The patent develops a universal labeling approach that can be applied to various types of protein dimers and aggregates, not just mAbs. The methodology uses general chemical labeling principles that work across different protein types, making the system versatile while managing complexity through standardized protocols and data analysis frameworks.
3Measurement precision
If detailed peptide mapping is performed to identify dimerization interfaces at residue level, then the information obtained is more precise, but the analysis time and computational resources increase
Solution Approach 1:
The patent performs preliminary enrichment of dimeric species and site-specific labeling before the actual peptide mapping analysis. By pre-concentrating the relevant species and introducing detectable labels that specifically mark the dimerization interface, the subsequent mass spectrometry analysis requires less computational processing time while maintaining high precision in interface identification.
Solution Approach 2:
The patent applies local quality enhancement by focusing the labeling reaction specifically on residues at the dimerization interface through controlled chemical conditions. This localized labeling approach means that only relevant regions are heavily labeled, reducing the complexity of data analysis compared to global labeling, thereby decreasing analysis time while maintaining high precision at the interface regions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These methods enable successful mapping of heterogeneous dimerization interfaces, allowing for the reduction of dimerization and noncovalent interactions in protein drug products, thereby improving product quality by identifying and modifying conditions to minimize aggregation.
Implementation Method 1
digesting a protein dimer sample into subdomains
Implementation Method 2
labeling the digested protein sample mixture
Implementation Method 3
peptide mapping the labeled sample
Implementation Method 4
fast photochemical oxidation of proteins (FPOP)
Data Source
AI summary
Systems and methods to characterize dimerization interfaces at the subdomain level of a protein are provided. An exemplary method includes digesting a protein dimer sample into subdomains, labeling the digested protein sample, isolating labeled dimeric and monomeric subdomain fragments, and peptide mapping the labeled sample to determine where the dimer fragments are labeled and where the dimer fragments are not labeled. Regions that show decreased labeling extents in the dimer fraction than that in the monomer fraction are likely involved or in close proximity to the dimerization interface.